Victory for Mayo in neurological disorder patent dispute

In a victory for Mayo Collaborative Services, a US Court has ruled that four claims in a patent, of which Athena Diagnostics is the exclusive licensee, are invalid.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Amerigen loses patent case against UCB at Federal Circuit

14 January 2019 US-based Amerigen Pharmaceuticals has lost in its bid to prove that claims in a patent owned by biopharmaceutical company UCB were covered by a prior invention.

Big Pharma

Athena asks for rehearing on invalidated neurological disorder patent

9 April 2019 Athena Diagnostics has asked the US Federal Circuit to revisit its decision earlier this year, which found four claims in one of its patents to be invalid.

Americas

Federal Circuit refuses to rehear Athena dispute; judges call for reform

4 July 2019 The US Court of Appeals for the Federal Circuit has upheld a win for Mayo Collaborative Services after it denied Athena Diagnostics’ petition to have a neurological patent dispute reheard en banc.

More on this story

Americas

Amerigen loses patent case against UCB at Federal Circuit

14 January 2019 US-based Amerigen Pharmaceuticals has lost in its bid to prove that claims in a patent owned by biopharmaceutical company UCB were covered by a prior invention.

Big Pharma

Athena asks for rehearing on invalidated neurological disorder patent

9 April 2019 Athena Diagnostics has asked the US Federal Circuit to revisit its decision earlier this year, which found four claims in one of its patents to be invalid.

Americas

Federal Circuit refuses to rehear Athena dispute; judges call for reform

More on this story

Americas

Amerigen loses patent case against UCB at Federal Circuit

14 January 2019 US-based Amerigen Pharmaceuticals has lost in its bid to prove that claims in a patent owned by biopharmaceutical company UCB were covered by a prior invention.

Big Pharma

Athena asks for rehearing on invalidated neurological disorder patent

9 April 2019 Athena Diagnostics has asked the US Federal Circuit to revisit its decision earlier this year, which found four claims in one of its patents to be invalid.

Americas

Federal Circuit refuses to rehear Athena dispute; judges call for reform